Cancer trials: Search results
Results: 108 items found. Showing page 2 of 4.
Refine results
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers
Trial short name: Codebreak 202
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 3
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-NORTH AMERICA)
Trial short name: CRC.10
Cancer type: Gastrointestinal
Cancer location: Colon
Disease stage: Early Cancer
Trial phase: Phase 2, Phase 3
A Randomized, Parallel Group Study to Evaluate the Safety, Pharmacokinetics, and Dose Response of Paltusotine Treatment in Subjects with Carcinoid Syndrome
Trial short name: CRN00808-11
Cancer type: Neuroendocrine
Cancer location: Neuroendocrine
Disease stage: Early Cancer
Trial phase: Phase 2
An International Multicenter Randomized Controlled Trial to Compare Combined Portal and Hepatic Vein Embolization (PVE/HVE) With PVE Alone in Patients With Colorectal Liver Cancer Metastases (CRLM) and a Small Future Liver Remnant (FLR)
Trial short name: DRAGON-2
Cancer type: Gastrointestinal
Cancer location: Liver
Disease stage: Advanced Cancer
Trial phase: Other
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Trial short name: Elaine 3
Cancer type: Breast
Cancer location: Breast
Disease stage: Advanced Cancer
Trial phase: Phase 3
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ Defined by a Molecular Expression Assay Combined With Clinico-Pathological Features
Trial short name: ELISA
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Other
A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients who have Previously Received 2 to 5 years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer with an Increased Risk of Recurrence
Trial short name: EMBER-4
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 3
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Trial short name: EMPOWHER 303
Cancer type: Breast
Cancer location: Breast
Disease stage: Advanced Cancer
Trial phase: Phase 3
A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)
Trial short name: eVOLVE-Lung02
Cancer type: Lung
Cancer location: Lung
Disease stage: Early Cancer
Trial phase: Phase 3
A Randomized, 2-cohort, Double-blind, Placebo-controlled, Phase III Study of AZD5305 in Combination with Physician’s Choice New Hormonal Agents in Patients with HRRm and non-HRRm Metastatic Castration-Sensitive Prostate Cancer (EvoPAR-Prostate01)
Trial short name: EvoPAR-Prostate01
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase I Trial of the Combination of Olaparib and Navitoclax in Women with High Grade Serous Epithelial Ovarian Cancer and Triple Negative Breast Cancer
Trial short name: Exactis-03
Cancer type: Gynecology
Cancer location: Gynecology
Disease stage: Early Cancer
Trial phase: Phase 1
A Phase I Trial of the Combination of Olaparib and Navitoclax in Women with High Grade Serous Epithelial Ovarian Cancer and Triple Negative Breast Cancer
Trial short name: EXACTIS-03
Cancer type: Breast
Cancer location: Breast
Disease stage: Early Cancer
Trial phase: Phase 1
A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations
Trial short name: F8394-201
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 2
Feasibility of Integrating Rectal Hydrogel Spacer for Salvage Treatment using STereotactic Ablative Body Radiotherapy for Locally Recurrent Prostate Cancer (FIRST STAR)
Trial short name: FIRST STAR
Cancer type: Genitourinary
Cancer location: Prostate
Disease stage: Early Cancer
Trial phase:
Phase II Trial of Fecal Microbial Transplantation in Patients with Advanced Non-Small Cell Lung Cancer and Melanoma Treated with Immune Checkpoint Inhibitors
Trial short name: FMT-LUMINate
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 2
A Randomized Phase II Study of Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Positive Advanced Gastroesophageal Adenocarcinoma
Trial short name: GA.4
Cancer type: Gastrointestinal
Cancer location: Esophagus
Disease stage: Early Cancer
Trial phase: Phase 2
An International, Seamless Phase II/III Responsive Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Trial short name: GBM AGILE
Cancer type: Central Nervous System
Cancer location: Central Nervous System
Disease stage: Early Cancer
Trial phase: Phase 3
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician’s Choice in Participants With Endometrial Cancer Who Have Received Prior Platinum-based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
Trial short name: GOG-3104 (ASCENT-GYN-01)
Cancer type: Gynecology
Cancer location: Uterine / Endometrial
Disease stage: Advanced Cancer
Trial phase: Phase 3
A Phase II Study of the Rate of Conversion to Complete Resection in Patients with Initially Inoperable Hepatic-Only Metastases From Colorectal Cancer After Treatment With Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination with Best Systemic Chemotherapy
Trial short name: HAIP-6192
Cancer type: Gastrointestinal
Cancer location: Colorectal
Disease stage: Advanced Cancer
Trial phase: Phase 2
Sunnybrook Hematology Biobank (CMH Biobank)
Trial short name: Heme Biobank
Cancer type: Blood Related
Cancer location: Blood Related
Disease stage: Early Cancer
Trial phase:
SPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
Trial short name: HN.11
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Early Cancer
Trial phase: Phase 3
A Phase III Randomized Controlled Trial Comparing Palliative Stereotactic Body Radiotherapy vs. Palliative Standard Radiotherapy in Patients with Advanced Head and Neck Cancer
Trial short name: HN13
Cancer type: Head & Neck
Cancer location: Head & Neck
Disease stage: Advanced Cancer
Trial phase: Phase 3
HSIL/ACIS/Early Cervical Cancer: What Are The Current Causative HPV Subtypes in the Era of HPV Vaccination?
Trial short name: HPV Subtypes
Cancer type: Gynecology
Cancer location: Cervix
Disease stage: Early Cancer
Trial phase: Other
FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)
Trial short name: HPVDNA02
Cancer type: Gynecology
Cancer location: Cervix
Disease stage: Early and Advanced Cancer
Trial phase: Other
A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or Chemotherapy or TransCon TLR7/8 Agonist in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies (IL Believe)
Trial short name: IL Believe
Cancer type: Melanoma
Cancer location: Melanoma
Disease stage: Early Cancer
Trial phase: Phase 1, Phase 2
